Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

bb pharma a.s., praha array - 4980 hemihydrÁt kalium-dl-hydrogen-aspartÁtu; 4983 tetrahydrÁt magnesium-hydrogen-dl-aspartÁtu - injekční/infuzní roztok - 50mg/ml+50mg/ml - kombinace elektrolytŮ

Европейски съюз - чешки - EMA (European Medicines Agency)

bayer ag - riociguat - hypertenze, plicní - antihypertenzíva pro plicní arteriální hypertenzi - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. Účinnost byla prokázána v pau populace, včetně etiologie idiopatické nebo dědičné pah nebo pah spojenou s onemocněním pojivové tkáně. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

pascoe pharmazeutische praparate gmbh, giessen array - 102 kyselina askorbovÁ - koncentrát pro infuzní roztok - 150mg/ml - kyselina askorbovÁ (vitamin c)

Европейски съюз - чешки - EMA (European Medicines Agency)

eli lilly nederland b.v. - tadalafil - hypertenze, plicní - urologika - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. Účinnost byla prokázána u idiopatické pah (ipah) a u pah souvisejících s vaskulárním onemocněním kolagenu. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.

Европейски съюз - чешки - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hypertenze, plicní - antihypertenziva, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

medac gesellschaft für klinische spezialpräparate m.b.h., wedel array - 12330 vinorelbin-ditartarÁt - koncentrát pro infuzní roztok - 10mg/ml - vinorelbin

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

medac gesellschaft für klinische spezialpräparate m.b.h., wedel array - 19572 abirateron-acetÁt - tableta - 250mg - abirateron

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

medac gesellschaft für klinische spezialpräparate m.b.h., wedel array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

medac gesellschaft für klinische spezialpräparate m.b.h., wedel array - 12330 vinorelbin-ditartarÁt - měkká tobolka - 20mg - vinorelbin

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

medac gesellschaft für klinische spezialpräparate m.b.h., wedel array - 12330 vinorelbin-ditartarÁt - měkká tobolka - 30mg - vinorelbin